Authors
Latest:
Unraveling the genetics of glaucomaDetails enhance knowledge of biological pathways that contribute to disease pathogenesis.
Latest:
Real-world outcomes validate intraocular drug delivery methodOphthalmologists seek methods to control postoperative inflammation.
Latest:
Q&A: Jay Chhablani, MD, discusses 3D choroidal vasculature analysisJay Chhablani, MD, explains how 3D choroidal vessel segmentation transforms ophthalmology, enhancing disease diagnosis and treatment through advanced imaging technology.
Latest:
Envision Summit 2025: Eradicating TRDAt the Envision Summit 2025 in San Juan, Puerto Rico, Kristen Nwanyanwu, MD, MBA, MHS, joined by her children, discussed her talk on eradicating TRD and the family-friendly environment of the conference.
Latest:
Clinical Implications of Port Delivery System in Retinal DiseasesClosing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.
Latest:
ZEISS VISULAS Combi availability expands to CanadaZEISS VISULAS Combi is an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp technology in a single, comprehensive solution.
Latest:
Celebrating women in leadershipIn ophthalmology, women continue to take on leadership roles and make a difference in the profession.
Latest:
A Cataract Case Study with Dr. Rahul PanditUsing an NSAID to Manage Inflammation and Pain After Cataract Surgery
Latest:
Ophthalmologist Holocaust survivor shares his storyIn observance of International Holocaust Remembrance Day this January 27, John H. Merey, MD, may be the only Holocaust survivor still in the practice of ophthalmology.
Latest:
Promoting Treatment Adherence in nAMD and DMEExperts discuss the use of steroids, particularly in the context of diabetic macular edema (DME). The inflammatory nature of DME reveals the effectiveness of steroids, especially in cases where persistent fluid remains despite anti-VEGF treatment.
Latest:
Virtual reality brings care to at-need areasTechnology offers accessibility, scalability to countries where care is needed the most.
Latest:
A new era for MacTel: Clinicians react to FDA approval of revakinagene taroretcel-lweyInsights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal disease
Latest:
Envision Summit 2025: Managing add-ons in a busy retina clinicAt the Envision Summit 2025 in San Juan, Puerto Rico, Ollya Fromal, MD, gave advice on how retina specialists can manage add-ons in their busy retina clinics.
Latest:
Ocular manifestations of mycoplasma-induced rash and mucositisAggressive lubrication combined with topical steroids, antibiotics boosts chances of recovery.
Latest:
Pivotal study data drive glaucoma patient treatment decisionsTwo trials examine factors affecting the risk of disease.
Latest:
Clearing hurdles to large scale telemedicine adoptionDuring the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye
Latest:
Low-dose atropine causes esotropia in patient caseClinician highlights a novel complication of atropine treatment in a teenage patient.
Latest:
Advancements in ocular drug deliveryOptions empower patients and providers to decrease treatment burden.
Latest:
Focus on molecular mechanisms underlying cataract developmentSeveral hundred genes are associated with congenital forms.
Latest:
Cataract surgery pearls for cases with poor mydriasis, zonulesFactors that lead to complications must be managed for best outcomes.
Latest:
Retinoblastoma care goes digital: insights from two decades of teleophthalmologyNathan Congdon, MD, highlights a recent study showing how virtual mentor-mentee relationships through Orbis' free telemedicine and e-learning platform can significantly enhance care.
Latest:
Unraveling the genetics of glaucomaDetails enhance knowledge of biological pathways that contribute to disease pathogenesis.
Latest:
What increased depth of focus can mean to your monofocal IOL patientsEnhanced monofocal IOLs provide a slight depth-of-focus boost without compromising contrast, making them a versatile choice for patients seeking improved distance and intermediate vision while still needing glasses for near tasks.
Latest:
Advances in Technology for SMILE procedureJohn Doane, MD, discusses latest advancements in laser technology that enhance the surgical experience, speed, and precision of the SMILE procedure.
Latest:
EnVision Summit 2025: Complications in glaucoma surgeryAt the EnVision Summit 2025 in San Juan, Puerto Rico, Tania Tai, Lucy Shen, and Shivani Kamat all gave insight into complications they have seen while performing glaucoma surgery.
Latest:
ARVO 2025: LUGANO and LUCIA trial designAt the ARVO 2025 Annual Meeting in Salt Lake City, Utah, Nimesh Patel, MD, presented on the LUCIA and LUGANO phase 3 pivotal trials for EYP-1901 against aflibercept for the treatment of wet macular degeneration.
Latest:
FLIO and the brain: Making the invisible visible with Robert Sergott, MDThis noninvasive imaging tool reveals early brain pathology through the eye, promising faster and more accurate diagnoses as highlighted at the Heidelberg 2025 International SPECTRALIS Symposium – And Beyond (ISS).
